IMAX Corporation (IMAX) PT Raised to $25 at Benchmark on F9'S Record Post-Pandemic Results

May 24, 2021 6:43 AM EDT
Get Alerts IMAX Hot Sheet
Price: $16.81 -1.18%

Rating Summary:
    10 Buy, 7 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 15 | New: 24
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Benchmark analyst Mike Hickey raised the price target on IMAX Corporation (NYSE: IMAX) to $25.00 while maintaining a Buy rating on the strength of movie F9, particularly in China.

The analyst commented, "F9 delivered an estimated $162M in its 8-market debut and $135M from China alone, the best post pandemic start for a Hollywood blockbuster, and the 2nd best launch for the series in the country. F9 is the first Hollywood film in 2 years to debut more than $100M in China. IMAX delivered its biggest post-pandemic opening weekend for a Hollywood film on the release of F9. F9 generated $14M across 800 IMAX screens. We see continued evidence of a box office rebound and incremental optimism over the return of Hollywood films to China. IMAX appears to be gaining market share as movie-goers trend toward a premium theatrical experience. We are raising IMAX global box office projections based on reported results, movie-goer momentum, and a compelling film slate."

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change